BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 31399111)

  • 1. TET1-mediated DNA hydroxymethylation activates inhibitors of the Wnt/β-catenin signaling pathway to suppress EMT in pancreatic tumor cells.
    Wu J; Li H; Shi M; Zhu Y; Ma Y; Zhong Y; Xiong C; Chen H; Peng C
    J Exp Clin Cancer Res; 2019 Aug; 38(1):348. PubMed ID: 31399111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TET1 inhibits EMT of ovarian cancer cells through activating Wnt/β-catenin signaling inhibitors DKK1 and SFRP2.
    Duan H; Yan Z; Chen W; Wu Y; Han J; Guo H; Qiao J
    Gynecol Oncol; 2017 Nov; 147(2):408-417. PubMed ID: 28851501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TET1 exerts its anti-tumor functions via demethylating DACT2 and SFRP2 to antagonize Wnt/β-catenin signaling pathway in nasopharyngeal carcinoma cells.
    Fan J; Zhang Y; Mu J; He X; Shao B; Zhou D; Peng W; Tang J; Jiang Y; Ren G; Xiang T
    Clin Epigenetics; 2018 Aug; 10(1):103. PubMed ID: 30075814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TET1 suppresses colon cancer proliferation by impairing β-catenin signal pathway.
    Guo H; Zhu H; Zhang J; Wan B; Shen Z
    J Cell Biochem; 2019 Aug; 120(8):12559-12565. PubMed ID: 30825236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TET1 inhibits gastric cancer growth and metastasis by PTEN demethylation and re-expression.
    Pei YF; Tao R; Li JF; Su LP; Yu BQ; Wu XY; Yan M; Gu QL; Zhu ZG; Liu BY
    Oncotarget; 2016 May; 7(21):31322-35. PubMed ID: 27121319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secreted Frizzled Related Protein 2 Modulates Epithelial-Mesenchymal Transition and Stemness via Wnt/β-Catenin Signaling in Choriocarcinoma.
    Zeng X; Zhang Y; Xu H; Zhang T; Xue Y; An R
    Cell Physiol Biochem; 2018; 50(5):1815-1831. PubMed ID: 30396168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-300 promotes apoptosis and inhibits proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway by targeting CUL4B in pancreatic cancer cells.
    Zhang JQ; Chen S; Gu JN; Zhu Y; Zhan Q; Cheng DF; Chen H; Deng XX; Shen BY; Peng CH
    J Cell Biochem; 2018 Jan; 119(1):1027-1040. PubMed ID: 28685847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of TET1 facilitates DLD1 colon cancer cell migration via H3K27me3-mediated down-regulation of E-cadherin.
    Zhou Z; Zhang HS; Liu Y; Zhang ZG; Du GY; Li H; Yu XY; Huang YH
    J Cell Physiol; 2018 Feb; 233(2):1359-1369. PubMed ID: 28513825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TET1 downregulates epithelial-mesenchymal transition and chemoresistance in PDAC by demethylating CHL1 to inhibit the Hedgehog signaling pathway.
    Li H; Jiang W; Liu XN; Yuan LY; Li TJ; Li S; Xu SS; Zhang WH; Gao HL; Han X; Wang WQ; Wu CT; Yu XJ; Xu HX; Liu L
    Oncogene; 2020 Sep; 39(36):5825-5838. PubMed ID: 32753651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway.
    Neri F; Dettori D; Incarnato D; Krepelova A; Rapelli S; Maldotti M; Parlato C; Paliogiannis P; Oliviero S
    Oncogene; 2015 Aug; 34(32):4168-76. PubMed ID: 25362856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RUNX1 promotes tumour metastasis by activating the Wnt/β-catenin signalling pathway and EMT in colorectal cancer.
    Li Q; Lai Q; He C; Fang Y; Yan Q; Zhang Y; Wang X; Gu C; Wang Y; Ye L; Han L; Lin X; Chen J; Cai J; Li A; Liu S
    J Exp Clin Cancer Res; 2019 Aug; 38(1):334. PubMed ID: 31370857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of Wnt5a promotes epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells.
    Bo H; Zhang S; Gao L; Chen Y; Zhang J; Chang X; Zhu M
    BMC Cancer; 2013 Oct; 13():496. PubMed ID: 24156409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA
    Wei Y; Zhu P
    Acta Pharm; 2024 Mar; 74(1):131-147. PubMed ID: 38554384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HOTAIR Knockdown Decreased the Activity Wnt/β-Catenin Signaling Pathway and Increased the mRNA Levels of Its Negative Regulators in Hela Cells.
    Salmerón-Bárcenas EG; Illades-Aguiar B; Del Moral-Hernández O; Ortega-Soto A; Hernández-Sotelo D
    Cell Physiol Biochem; 2019; 53(6):948-960. PubMed ID: 31820855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IQGAP1 promotes pancreatic cancer progression and epithelial-mesenchymal transition (EMT) through Wnt/β-catenin signaling.
    Hu W; Wang Z; Zhang S; Lu X; Wu J; Yu K; Ji A; Lu W; Wang Z; Wu J; Jiang C
    Sci Rep; 2019 May; 9(1):7539. PubMed ID: 31101875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KCTD11 inhibits progression of lung cancer by binding to β-catenin to regulate the activity of the Wnt and Hippo pathways.
    Yang M; Han YM; Han Q; Rong XZ; Liu XF; Ln XY
    J Cell Mol Med; 2021 Oct; 25(19):9411-9426. PubMed ID: 34453479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of TET1 Promotes Glioma Cell Proliferation and Invasion by Targeting Wnt/
    Ji J; You Q; Zhang J; Wang Y; Cheng J; Huang X; Zhang Y
    Anal Cell Pathol (Amst); 2021; 2021():8980711. PubMed ID: 34926132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tumor suppressor Zinc finger protein 471 suppresses breast cancer growth and metastasis through inhibiting AKT and Wnt/β-catenin signaling.
    Tao C; Luo J; Tang J; Zhou D; Feng S; Qiu Z; Putti TC; Xiang T; Tao Q; Li L; Ren G
    Clin Epigenetics; 2020 Nov; 12(1):173. PubMed ID: 33203470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the Wnt/β-catenin signaling pathway.
    Xu W; Wang Z; Zhang W; Qian K; Li H; Kong D; Li Y; Tang Y
    Cancer Lett; 2015 Jan; 356(2 Pt B):613-27. PubMed ID: 25305448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer.
    Sannino G; Armbruster N; Bodenhöfer M; Haerle U; Behrens D; Buchholz M; Rothbauer U; Sipos B; Schmees C
    Oncotarget; 2016 Nov; 7(45):73725-73738. PubMed ID: 27713160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.